ARROWHEAD PHARMACEUTICALS, INC. Debt Instrument, Interest Rate, Stated Percentage
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Debt Instrument, Interest Rate, Stated Percentage of 10.00% as of 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2014-05-06
- 2013-06-30: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
- 2013-03-31: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
- 2012-12-31: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
- 2008-11-26: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2013-06-30 | 10.00% 10-Q · filed 2013-08-07 |
| 2013-03-31 | 10.00% 10-Q · filed 2013-05-09 |
| 2012-12-31 | 10.00% 10-Q · filed 2013-02-13 |
| 2008-11-26 | 10.00% 10-Q · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |